|
DNA (Cytosine-5-)-Methyltransferase 1
|
D12.776.157.687.313 |
|
|
Cabergoline
|
D03.633.400.439.197 |
|
|
Short-Wave Therapy
|
E02.808.875 |
|
|
Infratemporal Fossa
|
A01.456.830.600 |
|
|
Egg Proteins, Dietary
|
D12.776.290.300 |
|
|
Hemolysin Factors
|
G05.360.600.430 |
|
|
Sympathetic Nervous System
|
A08.800.050.800 |
|
|
1-Methyl-3-isobutylxanthine
|
D03.633.100.759.758.824.751.500 |
|
|
Breakthrough Pain
|
G11.561.790.444.393 |
|
|
Rhabdomyosarcoma, Alveolar
|
C04.557.450.590.550.660.665 |
|
|
Tunica Intima
|
A07.015.700 |
|
|
Entomophthora
|
B01.300.300.300.300 |
|
|
Immunohistochemistry
|
H01.158.100.656.234.512 |
|
|
Histocytochemistry
|
H01.158.100.656.234 |
|
|
Insulin, Regular, Pork
|
D06.472.699.587.200.500.625.700 |
|
|
Cytochromes b6
|
D05.500.562.488.374.500 |
|
|
Cytochrome b6f Complex
|
D05.500.562.488.374 |
|
|
National Institute on Drug Abuse (U.S.)
|
N03.540.052.750.485 |
|
|
Anesthetics, Inhalation
|
D27.505.954.427.210.100.035.060 |
|
|
Anesthetics, General
|
D27.505.954.427.210.100.035 |
|
